[EN] DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS<br/>[FR] COMPOSÉS DE DIFLUOROLACTAME COMME AGONISTES SÉLECTIFS DU RÉCEPTEUR EP4, DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE MALADIES ET D'AFFECTIONS MÉDIÉES PAR EP4
申请人:CAYMAN CHEMICAL CO INC
公开号:WO2014015247A1
公开(公告)日:2014-01-23
Disclosed herein are compounds of formula (I) and therapeutic methods of treatment with compounds of formula (I), wherein L1, L2, L4, R1, R4, R5, R6, and s are as defined in the specification. Compounds of formula (I) are EP4 agonists useful in the treatment of glaucoma, neuropathic pain, and related disorders.